Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Mult Scler Relat Disord. 2019 Nov 1;37:101488. doi: 10.1016/j.msard.2019.101488

Table 1.

Identified Subjects with at Least One ICD-9-CM Code for NMO

All (n=219) CHOP (n=34) CMKC (n=16) SCH (n=4) UPHS (n=143) YNHH (n=22)
Demographics and Clinical Characteristics
Age, median (IQR) 39 (17,52) 12 (6,14) 8 (5,13) 12 (11,14) 44 (32, 56) 44 (27,54)
Female, n (%) 167 (76%) 22 (65%) 11 (69%) 4 (100%) 110 (77%) 20 (9%)
White race, n (%) 104 (51%) 18 (53%) 12 (75%) 1 (25%) 63 (44%) 10 (45%)
Positive Predictive Values
PPV for NMO/NMOSD 47% 41% 13% 0% 48% 77%
PPV for 2006 NMO criteria 22% 24% 6% 0% 21% 41%
PPV for 2015 NMOSD criteria 44% 41% 13% 0% 45% 73%
PPV for Physician Diagnosis 67% 41% 25% 50% 75% 91%

Legend. Gold standard is medical chart review demonstrating fulfillment of criteria for NMO and/or NMOSD respectively. IQR= interquartile range. PPV = positive predictive value. CHOP = The Children’s Hospital of Philadelphia. SCH = Seattle Children’s Hospital. CMKC = Children’s Mercy Kansas City. YNHH = Yale-New Haven Hospital. UPHS = the University of Pennsylvania Health System. NMO = neuromyelitis optica. NMOSD = neuromyelitis optica spectrum disorder.